Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L E Gustavson

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Therapeutics|May 17, 2001
Pharmacokinetics and tolerability of extended-release clarithromycinD R Guay, L E Gustavson, K J Devcich, et al.
Epilepsia|August 13, 1998
Population analysis of the pharmacokinetics of tiagabine in patients with epilepsyE E Samara, L E Gustavson, T El-Shourbagy, et al.
Epilepsy Research. Supplement|January 1, 1991
TiagabineM W Pierce, P D Suzdak, L E Gustavson, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1995
Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady stateL E Gustavson, J F Kaiser, A L Edmonds, et al.
American Journal of Therapeutics|March 31, 1999
Lack of a clinically significant pharmacokinetic drug interaction between tiagabine and valproateL E Gustavson, K W Sommerville, S W Boellner, et al.
Journal of Clinical Pharmacology|March 10, 2000
Lack of a clinically significant pharmacokinetic interaction between fenofibrate and pravastatin in healthy volunteersW J Pan, L E Gustavson, R Achari, et al.
Epilepsia|April 1, 1997
Pharmacokinetics and safety of tiagabine in subjects with various degrees of hepatic functionA H Lau, L E Gustavson, R Sperelakis, et al.
Epilepsy Research|November 1, 1995
Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugsE L So, D Wolff, N M Graves, et al.
American Journal of Therapeutics|March 31, 1999
Lack of pharmacokinetic drug interactions between tiagabine and carbamazepine or phenytoinL E Gustavson, A Cato, S W Boellner, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
Steady-state pharmacokinetics and electrocardiographic pharmacodynamics of clarithromycin and loratadine after individual or concomitant administrationR A Carr, A Edmonds, H Shi, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Therapeutics|May 17, 2001
Pharmacokinetics and tolerability of extended-release clarithromycinD R Guay, L E Gustavson, K J Devcich, et al.
Epilepsia|August 13, 1998
Population analysis of the pharmacokinetics of tiagabine in patients with epilepsyE E Samara, L E Gustavson, T El-Shourbagy, et al.
Epilepsy Research. Supplement|January 1, 1991
TiagabineM W Pierce, P D Suzdak, L E Gustavson, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1995
Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady stateL E Gustavson, J F Kaiser, A L Edmonds, et al.
American Journal of Therapeutics|March 31, 1999
Lack of a clinically significant pharmacokinetic drug interaction between tiagabine and valproateL E Gustavson, K W Sommerville, S W Boellner, et al.
Journal of Clinical Pharmacology|March 10, 2000
Lack of a clinically significant pharmacokinetic interaction between fenofibrate and pravastatin in healthy volunteersW J Pan, L E Gustavson, R Achari, et al.
Epilepsia|April 1, 1997
Pharmacokinetics and safety of tiagabine in subjects with various degrees of hepatic functionA H Lau, L E Gustavson, R Sperelakis, et al.
Epilepsy Research|November 1, 1995
Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugsE L So, D Wolff, N M Graves, et al.
American Journal of Therapeutics|March 31, 1999
Lack of pharmacokinetic drug interactions between tiagabine and carbamazepine or phenytoinL E Gustavson, A Cato, S W Boellner, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
Steady-state pharmacokinetics and electrocardiographic pharmacodynamics of clarithromycin and loratadine after individual or concomitant administrationR A Carr, A Edmonds, H Shi, et al.
Pageof 3